12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights 2 hours ago
Movers
Gainers Obsidian Therapeutics (NASDAQ:OBX) stock increased by 27.7% to $12.26 during Friday's regular session. The company's market cap stands at $593.0 million. TransMedics Group (NASDAQ:TMDX) shares rose
Gainers
- Obsidian Therapeutics (NASDAQ:OBX) stock increased by 27.7% to $12.26 during Friday's regular session. The company's market cap stands at $593.0 million.
- TransMedics Group (NASDAQ:TMDX) shares rose 23.73% to $85.36. The market value of their outstanding shares is at $2.3 billion. As per the news, the Q3 earnings report came out yesterday.
- CryoPort (NASDAQ:CYRX) shares moved upwards by 20.68% to $19.37. The market value of their outstanding shares is at $812.9 million. As per the press release, Q3 earnings came out yesterday.
- Dogwood Therapeutics (NASDAQ:DWTX) shares increased by 20.67% to $1.25. The company's market cap stands at $39.7 million. As per the news, the Q3 earnings report came out yesterday.
- Fulgent Genetics (NASDAQ:FLGT) shares moved upwards by 19.48% to $22.3. The market value of their outstanding shares is at $576.8 million. The company's, Q3 earnings came out yesterday.
- CG Oncology (NASDAQ:CGON) stock rose 19.02% to $77.12. The market value of their outstanding shares is at $5.7 billion. The company's, Q3 earnings came out today.
Losers
- AirSculpt Technologies (NASDAQ:AIRS) stock fell 57.8% to $0.61 during Friday's regular session. The market value of their outstanding shares is at $103.8 million. As per the news, the Q3 earnings report came out today.
- Biodesix (NASDAQ:BDSX) shares declined by 50.41% to $9.84. The market value of their outstanding shares is at $205.4 million. As per the press release, Q3 earnings came out yesterday.
- Baird Medical Investment (NASDAQ:BDMD) shares declined by 44.9% to $0.09. The company's market cap stands at $5.0 million.
- CVRx (NASDAQ:CVRX) stock declined by 42.76% to $0.84. The company's market cap stands at $39.0 million. As per the news, the Q3 earnings report came out yesterday.
- Virax Biolabs Group (NASDAQ:VRAX) shares declined by 38.23% to $0.73.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) shares fell 34.89% to $0.14. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.